Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2012
06/20/2012EP2465503A1 Pharmaceutical solution of cetirizine hydrochloride
06/20/2012EP2465497A1 Pharmaceutical suspension composition
06/20/2012EP2465496A1 Anti-acidosis pharmaceutical composition
06/20/2012EP2465495A1 Tablet that disintegrates rapidly in the mouth and that contains two or more types of particles
06/20/2012EP2465493A1 Topical compositions
06/20/2012EP2464727A2 Peptide libraries
06/20/2012EP2464664A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use
06/20/2012EP2464388A1 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents
06/20/2012EP2464387A2 Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method for use
06/20/2012EP2464377A1 Use of il-15 to increase thymic output and to treat lymphopenia
06/20/2012EP2464373A1 Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists
06/20/2012EP2464342A2 Novel pharmaceutical formulations against drug misuse
06/20/2012EP2464335A1 Pharmaceutical composition including a dha ester to be parenterally administered
06/20/2012EP2464334A1 Compositions and methods for treating fungal infection of the nail
06/20/2012EP2303233B1 Solid oral dosage form containing anti-platelet agent clopidogrel and method for the preparation thereof
06/20/2012EP2231710B1 Method for producing a hydroxyalkyl starch derivative with two linkers
06/20/2012EP1902718B1 Active foam
06/20/2012EP1877097B1 Aminoacid conjugates of beta-lapachone for tumor targeting
06/20/2012EP1852130B1 Medicine for external application containing anti-inflammatory agent and soy lecithin
06/20/2012EP1765411B1 Polymer-factor ix moiety conjugates
06/20/2012EP1694295B1 Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability
06/20/2012EP1562559B1 Bio-degradable colloid particles, in particular for pulmonary applications
06/20/2012EP1546203B1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
06/20/2012EP1487479B1 Mutant glycoproteins
06/20/2012EP1280557B1 Method for the preparation of polymeric micelle via phase separation of block copolymer
06/20/2012CN102510759A Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
06/20/2012CN102505176A Preparation method of laponite (LAP)-doped polylactic acid-glycolic acid (PLGA) nanofiber
06/20/2012CN102504291A pH sensitive type chitosan crosslinking povidone gel and preparation method and application thereof
06/20/2012CN102504290A Bead-shaped amphipathic nano particle as well as preparation method and application thereof
06/20/2012CN102504280A Method for preparing biofilm-imitated vesicle structure by utilizing modified hyper-branched polymer
06/20/2012CN102504245A Amphipathic amino acid block copolymer and preparation method and application thereof
06/20/2012CN102504229A Synthesis method of in-situ-enhanced thermosensitive polymer and degradable in-situ-enhanced injectable thermosensitive hydrogel
06/20/2012CN102504227A Process method for synthesizing lactic acid-lysine copolymer by catalytically opening loop and copolymerizing with acetic bicyclo-guanidine
06/20/2012CN102504215A Block copolymers and preparation method thereof
06/20/2012CN102504214A Process method for catalytic synthesis of poly lactic acid-glycolic acid by using bionic organic guanidinium
06/20/2012CN102504081A Preparation method of medicinal methacrylate resin polymer
06/20/2012CN102504068A Initiating agent for preparing polyamine amphiphilic block polyelectrolyte
06/20/2012CN102504046A Amphipathy polyethylene glycol stem grafting chitosan copolymer and preparation method and application thereof
06/20/2012CN102504045A Modified chitosan temperature-sensitive supramolecular gel based on host-guest property of cucurbituril, and preparation method and application thereof
06/20/2012CN102504015A Cardiovascular targeted small peptide MI-1 and application thereof
06/20/2012CN102504013A Target chemical drug PADM against cancer metastasis and preparation method and use thereof
06/20/2012CN102499986A Macromolecule-cis-platinum compound, preparation method and application thereof
06/20/2012CN102499985A Hard-shell capsule based on cellulose
06/20/2012CN102499981A Compositions and methods for topical application and transdermal delivery of botulinum toxins
06/20/2012CN102499980A Application of polypeptides to preparation of medicament for treating or preventing rheumatoid arthritis
06/20/2012CN102499971A Sugar-free brain-nourishing tablet for treating cardiovascular and cerebrovascular diseases and preparation method thereof
06/20/2012CN102499949A Ointment for treating chapped hands and feet
06/20/2012CN102499944A Nanometer silver antibiotic and antiviral compound liquid and its preparation method and products
06/20/2012CN102499943A Preparation and anti-tumor activity of polymer wrapped heteropoly acid nano hybrid material
06/20/2012CN102499935A Compound spiramycin nanoemulsion oral liquid and preparation method thereof
06/20/2012CN102499930A Medicinal fructose composition and preparation method thereof
06/20/2012CN102499923A Drug combination, as well as preparation method and application of same
06/20/2012CN102499915A Drug with Chinese rhubarb acid compound and preparation method of clathrate compound of Chinese rhubarb acid compound
06/20/2012CN102499909A Itraconazole dispersible tablets and preparation method thereof
06/20/2012CN102499908A Alvimopan solid preparation and preparation method thereof
06/20/2012CN102499907A Orally disintegrating tablet component
06/20/2012CN102499906A Rotigotine hydrochloride or free alkali film-forming gel preparation and preparation method thereof
06/20/2012CN102499905A Controllable photoresponse type hydrophobic medicament carrier hydrogel and preparation method thereof
06/20/2012CN102225050B Method for preparing famotidine sodium chloride injection by inclusion method and product prepared by using the same
06/20/2012CN102133224B Compound Iansoprazole chewable tablets
06/20/2012CN102058559B Doxycycline hydrochloride effervescent tables for milk cows and preparation method thereof
06/20/2012CN102008444B Preparation method of mitoxantrone-loaded dextran-polylactic acid copolymer nano particles
06/20/2012CN101991856B Preparation method of water-soluble inclusion compound of slightly soluble drug
06/20/2012CN101940554B Multi-core adhesive microspheres for loading water soluble low molecular medicament and preparation method thereof
06/20/2012CN101919799B Novel sustained-release transdermal medicament delivery system
06/20/2012CN101884624B Long-acting benserazide sustained release microsphere composition and preparation method thereof
06/20/2012CN101884614B Preparation of brain targeting chuanxiongzine oral oil package oil nano-emulsion
06/20/2012CN101862452B Method for preparing swine multi-valent antiserum compound preparation
06/20/2012CN101849909B Preparation method of magnetic disodium clodronate liposome
06/20/2012CN101838344B Chitosan nanoparticle with fluorescence labeling characteristic and method for preparing same
06/20/2012CN101822650B Minocycline hydrochloride sustained release tablet and preparation method thereof
06/20/2012CN101810570B Lipid nano particle preparation containing composite formed fatty acid and anthracyclines antitumor antibiotics and preparation method thereof
06/20/2012CN101810566B Hydrocortisone butyrate cream
06/20/2012CN101690734B Lactobacillus vaginal capsule and preparation method thereof
06/20/2012CN101584652B Risperidone sustained-release gel injection and preparation method thereof
06/20/2012CN101555212B Synthesized micromolecule compound capable of conveying bioactivator and application thereof
06/20/2012CN101474166B Cetirizine and pseudoephedrine sustained-release capsule and preparation method thereof
06/20/2012CN101439048B Chinese medicine glue rapid-release preparation for oral cavity and method for producing the same
06/20/2012CN101437935B Method of producing s-adenosyl-l-methionine-containing dry yeast having excellent storage stability, the product thereof and composition for oral intake
06/20/2012CN101112373B Methods of administering epothilone analogs for the treatment of cancer
06/19/2012US8203029 Silver-containing compositions, devices and methods for making
06/19/2012US8202980 Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference
06/19/2012US8202979 siNA molecule comprising a double-stranded structure that down-regulates expression of a target nucleic acid, wherein said siNA molecule does not require a 2'-hydroxyl group containing ribonucleotide; treating viral diseases such as SARS (severe acute respiratory syndrome virus), herpes, hepatitis, HIV
06/19/2012US8202912 Pharmaceutical compositions providing enhanced drug concentrations
06/19/2012US8202850 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
06/19/2012US8202540 Method for controlled production of ultrafine microparticles and nanoparticles
06/19/2012US8202524 Method for producing microspheres loaded with drugs and microspheres loaded with drugs produced thereby
06/19/2012US8202523 Glycosylated polypeptides produced in yeast mutants and methods of use thereof
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012US8202512 Metabolic uncoupling therapy
06/19/2012CA2702603C Sulfoalkyl ether cyclodextrin compositions
06/19/2012CA2669324C Method for preparing sustained release tablet
06/19/2012CA2626558C Pharmaceutical composition having reduced abuse potential
06/19/2012CA2534565C Reconstitution medium for protein and peptide formulations
06/19/2012CA2524179C A composition and its use for adminstration of mitomycin c in vivo for treating a multi-drug resistant tumor
06/19/2012CA2523844C Stable thrombin composition
06/19/2012CA2478012C Internalizing anti-cd74 antibodies and methods of use
06/19/2012CA2349202C Method of preparing stable suspensions of insoluble microparticles
06/19/2012CA2312976C Compositions comprising histidine-linked protein polymer conjugates
06/14/2012WO2012079093A2 Dosage and administration of bispecific scfv conjugates
1 ... 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 ... 1712